Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

Despite the recent development of immunotherapies that target programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC) treatment, these therapies are less effective in NSCLC patients with epidermal growth factor receptor (EGFR) mutations. However, the mole...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Suda, Kenichi, Rozeboom, Leslie, Furugaki, Koh, Yu, Hui, Melnick, Mary Ann C., Ellison, Kim, Rivard, Christopher J., Politi, Katerina, Mitsudomi, Tetsuya, Hirsch, Fred R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651099/
https://ncbi.nlm.nih.gov/pubmed/29119113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7694202
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky